Belite Bio reported total assets of $791.58M and total liabilities of $14.95M for the quarter ended Jun 2026, up 406.1% year over year. This balance sheet covers 18 quarters of results from Dec 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2020 | Dec2021 | Jun2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accumulated Depreciation | 0.05M | 0.09M | 0.18M | 0.34M | 0.51M | |||||||||||||
| Receivables - AccuredAcc. Int. Receivables | 0.63M | |||||||||||||||||
| Assets | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 17.34M | 42.09M | 88.16M | 31.68M | 157.03M | 352.93M | ||||||||||||
| Receivables - NetNet Receivables | 0.00M | 0.02M | ||||||||||||||||
| Receivables - OtherOther Receivables | 0.00M | -0.03M | -0.06M | 0.06M | 0.57M | 0.01M | 0.70M | |||||||||||
| Receivables | -0.03M | -0.04M | ||||||||||||||||
| Prepaid Assets | 0.09M | 0.72M | 0.95M | 1.35M | 1.59M | 1.15M | ||||||||||||
| Current Assets | 17.43M | 49.93M | 42.81M | 38.42M | 59.14M | 56.13M | 89.94M | 96.47M | 113.86M | 111.27M | 147.07M | 159.29M | 150.97M | 277.21M | 494.27M | 521.86M | 501.60M | |
| Non-Current Assets | ||||||||||||||||||
| Property, Plant & Equipment (Net) | 0.09M | 0.54M | 0.49M | 0.44M | 0.32M | 0.34M | ||||||||||||
| Long-Term Investments | 280.17M | |||||||||||||||||
| Intangibles | 0.03M | 0.02M | 0.02M | |||||||||||||||
| Goodwill & Intangibles | 0.03M | 0.02M | 0.02M | |||||||||||||||
| Other Non-Current Assets | 0.92M | 1.13M | 0.03M | 1.40M | 1.56M | 1.46M | 3.30M | 4.68M | 4.57M | 4.55M | 3.96M | 4.91M | 5.44M | 4.23M | 286.28M | 289.41M | 289.98M | |
| Non-Current Assets | 0.92M | 1.13M | 1.47M | 1.40M | 1.56M | 1.46M | 4.70M | 4.68M | 4.57M | 4.55M | 5.06M | 4.91M | 5.44M | 5.18M | 286.28M | 289.41M | 289.98M | |
| Assets | 18.35M | 51.06M | 44.27M | 39.82M | 60.70M | 57.60M | 94.64M | 101.15M | 118.43M | 115.82M | 152.13M | 164.20M | 156.41M | 282.39M | 780.56M | 811.27M | 791.58M | |
| Liabilities | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Notes Payables | 0.07M | |||||||||||||||||
| Payables | 0.07M | |||||||||||||||||
| Accumulated Expenses | 1.56M | 1.91M | 3.33M | 5.76M | 7.79M | 9.64M | ||||||||||||
| Other Accumulated Expenses | 0.15M | 0.27M | 0.15M | 0.29M | 0.60M | |||||||||||||
| Current Leases | 0.20M | 0.31M | 0.28M | 0.27M | 0.24M | |||||||||||||
| Total Current Liabilities | 1.64M | 2.10M | 3.63M | 6.05M | 8.07M | 9.88M | ||||||||||||
| Non-Current Liabilities | ||||||||||||||||||
| Preferred Stock Liabilities | 31.81M | 31.81M | ||||||||||||||||
| Operating Leases | 0.67M | 0.58M | 0.26M | 0.24M | 0.19M | |||||||||||||
| Total Non-Current Liabilities | 0.26M | 0.19M | ||||||||||||||||
| Total Liabilities | 7.04M | 1.64M | 1.43M | 2.77M | 4.65M | 4.98M | 4.80M | 4.21M | 4.68M | 3.84M | 3.62M | 6.31M | 6.13M | 6.52M | 8.31M | 10.07M | 15.48M | 14.95M |
| Shareholder's Equity | ||||||||||||||||||
| Total Debt | 0.07M | |||||||||||||||||
| Common Equity | -7.04M | -15.09M | 49.63M | 41.50M | 35.17M | 55.72M | 52.79M | 90.43M | 96.47M | 114.59M | 112.20M | 145.82M | 158.07M | 149.88M | 274.08M | 770.49M | 795.79M | 776.64M |
| Liabilities and Shareholders Equity | 18.35M | 51.06M | 44.27M | 39.82M | 60.70M | 57.60M | 94.64M | 101.15M | 118.43M | 115.82M | 152.13M | 164.20M | 156.41M | 282.39M | 780.56M | 811.27M | 791.58M | |
| Retained Earnings | -17.60M | 12.32M | 81.76M | 162.31M | 254.12M | 434.44M | 956.28M | |||||||||||
| Treasury Shares | 7.82M | 7.82M |